AustinPx Live Episode 5: Re-thinking ASD Development: When Your Molecule Breaks the Rules

Chief Scientific Officer, Dave Miller, Ph.D., will explore how KinetiSol™ is reshaping the design space for amorphous solid dispersions (ASDs). He’ll break down how our solvent-free platform enables rapid screening, broader excipient use, and higher-performing formulations compared to conventional technologies like spray drying or HME. The session will also address scalability, process efficiency, and why more teams are turning to KinetiSol earlier in development. This 30-minute session includes a 25-minute presentation followed by live Q&A.